BCL2 and breast cancer: We previously demonstrated that pre-miR-34a can mediate a dramatic decrease in the clonogenicity of MI-BC cell lines via inhibition of Cdk6, a cell cycle regulator; however, it also caused increased Bcl-2 expression and thereby decreased levels of apoptosis [26].